EFFECT OF PLATELET-ACTIVATING-FACTOR ANTAGONIST CV3988 IN AN AUTOLOGOUS NEPHROTOXIC NEPHRITIS MODEL

被引：0
|
作者：
HRUBY, Z [1 ]
LOWRY, RP [1 ]
BLAIS, D [1 ]
机构：
[1] MCGILL UNIV,ROYAL VICTORIA HOSP,DEPT MED,MONTREAL H3A 1A1,QUEBEC,CANADA
来源：
CLINICAL RESEARCH | 1986年 / 34卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A602 / A602
页数：1
相关论文
共 50 条
  • [41] PLATELET-ACTIVATING-FACTOR OR A PLATELET-ACTIVATING-FACTOR ANTAGONIST DECREASES TUMOR-NECROSIS-FACTOR-ALPHA IN THE PLASMA OF MICE TREATED WITH ENDOTOXIN
    FERGUSONCHANOWITZ, KM
    KATOCS, AS
    PICKETT, WC
    KAPLAN, JB
    SASS, PM
    ORONSKY, AL
    KERWAR, SS
    JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (05): : 1081 - 1086
  • [42] TRIAZOLAM IS SOMETHING ELSE - IT IS A PAF (PLATELET-ACTIVATING-FACTOR) ANTAGONIST
    ADAM, K
    OSWALD, I
    ANAESTHESIST, 1992, 41 (02): : 103 - 106
  • [43] INTERSPECIES SCALING OF A THIENODIAZEPINE PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST
    ELDER, CA
    MODI, MW
    DRUG METABOLISM AND DISPOSITION, 1995, 23 (07) : 776 - 778
  • [44] INFARCT REDUCTION BY THE PLATELET-ACTIVATING-FACTOR ANTAGONIST APAFANT IN RATS
    BIELENBERG, GW
    WAGENER, G
    BECK, T
    STROKE, 1992, 23 (01) : 98 - 103
  • [45] ABT-299, A POTENT ANTAGONIST OF PLATELET-ACTIVATING-FACTOR
    SUMMERS, JB
    ALBERT, DH
    DAVIDSEN, SK
    CONWAY, RG
    HOLMS, JH
    MAGOC, TJ
    LUO, GJ
    TAPANG, P
    RHEIN, DA
    CARTER, GW
    PROSTAGLANDINS AND RELATED COMPOUNDS: NINTH INTERNATIONAL CONFERENCE, FLORENCE, ITALY, 1995, 23 : 475 - 477
  • [46] EFFECT OF PLATELET-ACTIVATING-FACTOR ANTAGONIST AND LEUKOTRIENE ANTAGONIST ON ENDOTOXIN-SHOCK IN THE RAT - ROLE OF THE LEUKOCYTE
    YOSHIKAWA, D
    GOTO, F
    CIRCULATORY SHOCK, 1992, 38 (01) : 29 - 33
  • [47] THE EFFECT OF THE PLATELET-ACTIVATING-FACTOR ANTAGONIST BN-52021 ON THE HYPERGLYCEMIA INDUCED BY ALLOXAN
    EGIDO, J
    HERNANDO, P
    ROBLES, A
    DENICOLAS, R
    ROVIRA, A
    CASLA, A
    SARASA, J
    PROSTAGLANDINS, 1987, 34 (02): : 188 - 188
  • [48] EFFECT OF A PLATELET-ACTIVATING-FACTOR ANTAGONIST ON PANCREAS PERFUSION AFTER 24 H OF ISCHEMIA
    LEONHARDT, U
    EXNER, B
    SCHROCK, E
    RITZEL, U
    NEBENDAHL, K
    STOCKMANN, F
    PANCREAS, 1995, 11 (02) : 160 - 164
  • [49] THE EXVIVO EFFECT OF AN ORAL PLATELET-ACTIVATING-FACTOR ANTAGONIST (RP-59227) ON CHEMOTAXIS
    HOPP, RJ
    EDA, R
    BEWTRA, AK
    DOWLING, P
    TOWNLEY, RG
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (01) : 170 - 170
  • [50] EFFECT OF SENNA IS NOT MEDIATED BY PLATELET-ACTIVATING-FACTOR
    CAPASSO, F
    IZZO, AA
    MASCOLO, N
    AUTORE, G
    DICARLO, G
    PHARMACOLOGY, 1993, 47 : 58 - 63
12345